Primera is dedicated to advancing its programs to be the first into the clinic applying gene editing technologies directly to the mitochondrial genetic mutations that drive mitochondrial disease and potentially broader disease targets that have mitochondrial dysfunction as a key driver.
Pipeline: Multiple Mitochondrially Driven Disorders
